Gastrointestinal: Immune-related sclerosing cholangitis with pembrolizumab: Imaging and histological features

被引：3
|
作者：
Suzuki, N. [1 ]
Ikeda, Y. [1 ]
Ono, M. [1 ]
Ohmori, G. [1 ]
Maeda, M. [1 ]
机构：
[1] Steel Mem Muroran Hosp, Dept Gastroenterol, Muroran, Hokkaido, Japan
来源：
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY | 2022年 / 37卷 / 09期
关键词：
D O I：
10.1111/jgh.15797
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1652 / 1652
页数：1
相关论文
共 50 条
  • [1] Pembrolizumab-induced immune-related sclerosing cholangitis
    Li, Yuchen
    Stewart, Lori
    Tang, Shangguo
    McWhirter, Elaine
    [J]. BMJ CASE REPORTS, 2023, 16 (11)
  • [2] Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab:A case report
    Takeshi Tanaka
    Arata Sakai
    Masahiro Tsujimae
    Yasutaka Yamada
    Takashi Kobayashi
    Atsuhiro Masuda
    Yuzo Kodama
    [J]. World Journal of Gastroenterology, 2022, (28) : 3732 - 3738
  • [3] Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report
    Tanaka, Takeshi
    Sakai, Arata
    Tsujimae, Masahiro
    Yamada, Yasutaka
    Kobayashi, Takashi
    Masuda, Atsuhiro
    Kodama, Yuzo
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (28) : 3732 - 3738
  • [4] Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis
    Takinami, Masaki
    Ono, Akira
    Kawabata, Takanori
    Mamesaya, Nobuaki
    Kobayashi, Haruki
    Omori, Shota
    Wakuda, Kazushige
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Kiyohara, Yoshio
    Yasui, Hirofumi
    Niwakawa, Masashi
    Takahashi, Toshiaki
    [J]. INVESTIGATIONAL NEW DRUGS, 2021, 39 (06) : 1716 - 1723
  • [5] Comparison of clinical features between immune-related sclerosing cholangitis and hepatitis
    Masaki Takinami
    Akira Ono
    Takanori Kawabata
    Nobuaki Mamesaya
    Haruki Kobayashi
    Shota Omori
    Kazushige Wakuda
    Hirotsugu Kenmotsu
    Tateaki Naito
    Haruyasu Murakami
    Masahiro Endo
    Yoshio Kiyohara
    Hirofumi Yasui
    Masashi Niwakawa
    Toshiaki Takahashi
    [J]. Investigational New Drugs, 2021, 39 : 1716 - 1723
  • [6] Simultaneous occurrence of autoimmune pancreatitis and sclerosing cholangitis as immune-related adverse events of pembrolizumab
    Suda, Tsuyoshi
    Kobayashi, Masako
    Kurokawa, Koji
    Matsushita, Eiki
    [J]. BMJ CASE REPORTS, 2021, 14 (06)
  • [7] Multiple drugsPyogenic liver abscesses secondary to immune-related sclerosing cholangitis
    [J]. Reactions Weekly, 2023, 1987 (1) : 172 - 172
  • [8] Immune-related adverse event-associated sclerosing cholangitis due to immune checkpoint inhibitors: imaging findings and treatments
    Okamoto, Kohei
    Hijioka, Susumu
    Nagashio, Yoshikuni
    Okada, Mao
    Ohba, Akihiro
    Maruki, Yuta
    Kondo, Shunsuke
    Morizane, Chigusa
    Ueno, Hideki
    Okusaka, Takuji
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024, 54 (08) : 887 - 894
  • [9] Histological features of autoimmune pancreatitis and IgG4-related sclerosing cholangitis with a correlation with imaging findings
    Kenji Notohara
    [J]. Journal of Medical Ultrasonics, 2021, 48 : 581 - 594
  • [10] Histological features of autoimmune pancreatitis and IgG4-related sclerosing cholangitis with a correlation with imaging findings
    Notohara, Kenji
    [J]. JOURNAL OF MEDICAL ULTRASONICS, 2021, 48 (04) : 581 - 594
12345